Literature DB >> 518724

The effect of thoracic duct drainage on lymphocyte dynamics and clinical symptoms in patients with rheumatoid arthritis.

T Ueo, S Tanaka, Y Tominaga, H Ogawa, T Sakurami.   

Abstract

Thoracic duct drainage (TDD) was performed in 4 patients with severe rheumatoid arthritis. Clinical effects were apparent in all during drainage, but the term of TDD and the cumulative number of lymphocytes drained had no direct relation to the improvement of clinical symptoms. The number of lymphocytes in the peripheral blood increased despite discharge of lymphocytes from the thoracic duct in the very early stage of drainage, suggesting that lymph drainage from thoracic duct accelerates migration of lymphocytes from lymphocyte pools to the blood stream. Biopsy specimens of synovial membranes obtained post-TDD showed marked decrease of mononuclear cell infiltration as compared to the specimens obtained preoperatively. These findings suggest that clinical effectiveness may be due not only to systemic immunosuppression induced by lymphocyte depletion but also to accelerated migration of inflammatory cells from the synovial tissues to the blood stream occurring with dynamic change of lymph flow during TDD.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 518724     DOI: 10.1002/art.1780221217

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  11 in total

Review 1.  Anti-CD4 monoclonal antibodies in rheumatoid arthritis.

Authors:  E H Choy; G H Kingsley; G S Panayi
Journal:  Springer Semin Immunopathol       Date:  1998

Review 2.  Treatment of severe rheumatoid arthritis.

Authors:  V Wright
Journal:  Br Med J (Clin Res Ed)       Date:  1986-02-15

Review 3.  Lymphocyte traffic, endothelium, and rheumatoid arthritis.

Authors:  D Haskard
Journal:  Ann Rheum Dis       Date:  1987-12       Impact factor: 19.103

4.  Removal of lymphocytes in rheumatoid arthritis.

Authors:  A M Denman
Journal:  Br Med J (Clin Res Ed)       Date:  1981-12-05

5.  Activation pathways of synovial T lymphocytes. Expression and function of the UM4D4/CDw60 antigen.

Authors:  D A Fox; J A Millard; L Kan; W S Zeldes; W Davis; J Higgs; F Emmrich; R W Kinne
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

Review 6.  The optimum management of arthropathies.

Authors:  C S Wolfe; G R Hughes
Journal:  Drugs       Date:  1988-09       Impact factor: 9.546

7.  Clonal heterogeneity of synovial fluid T lymphocytes from patients with rheumatoid arthritis.

Authors:  A D Duby; A K Sinclair; S L Osborne-Lawrence; W Zeldes; L Kan; D A Fox
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

8.  Lymphapheresis as compared with rest period in treatment of severe rheumatoid arthritis.

Authors:  A M Boerbooms; D J De Rooy; P J Geerdink; L B Van de Putte; F A Van den Ouweland
Journal:  Clin Rheumatol       Date:  1984-03       Impact factor: 2.980

9.  Characterisation of activated lymphocytes in the peripheral blood of patients with rheumatoid arthritis.

Authors:  S D Carter; P A Bacon; N D Hall
Journal:  Ann Rheum Dis       Date:  1981-06       Impact factor: 19.103

Review 10.  Treating very early rheumatoid arthritis.

Authors:  Karim Raza; Caitriona E Buckley; Mike Salmon; Christopher D Buckley
Journal:  Best Pract Res Clin Rheumatol       Date:  2006-10       Impact factor: 4.098

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.